Plasmodium species are protozoan parasites that cause malaria, proliferating within host red blood cells and transmitted primarily by Anopheles mosquitoes.
Hyperbaric oxygen therapy could potentially hinder Plasmodium species growth by increasing oxygen levels, thereby disrupting their preference for low-oxygen environments and boosting the patient’s immune response.